These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30468532)

  • 21. Skin and nail infections due to Fusarium oxysporum in Tuscany, Italy.
    Romano C; Miracco C; Difonzo EM
    Mycoses; 1998 Nov; 41(9-10):433-7. PubMed ID: 9916472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections.
    Stasko N; McHale K; Hollenbach SJ; Martin M; Doxey R
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
    Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of mycological investigations in diagnostics of nail changes.
    Maleszka R; Ratajczak-Stefańska V; Mikulska D
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():36-8. PubMed ID: 16119622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis.
    Gupta AK; Talukder M; Carviel JL; Cooper EA; Piguet V
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1706-1717. PubMed ID: 37210652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in topical and systemic antifungals.
    Zhang AY; Camp WL; Elewski BE
    Dermatol Clin; 2007 Apr; 25(2):165-83, vi. PubMed ID: 17430754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosing and treating of onychomycosis].
    Tolstrup J; Jemec GB; Hare RK; Arendrup MC; Saunte DM
    Ugeskr Laeger; 2018 May; 180(20):. PubMed ID: 29761779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superficial fungal infections. A practical guide for primary care physicians.
    Pariser DM
    Postgrad Med; 1990 Apr; 87(5):205-14. PubMed ID: 2138735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review.
    Kumar L; Verma S; Bhardwaj A; Vaidya S; Vaidya B
    Artif Cells Nanomed Biotechnol; 2014 Feb; 42(1):32-46. PubMed ID: 23452349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
    Gupta AK; Einarson TR; Summerbell RC; Shear NH
    Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology and management of onychomycosis in private dermatological practice in France].
    Guibal F; Baran R; Duhard E; Feuilhade de Chauvin M
    Ann Dermatol Venereol; 2008; 135(8-9):561-6. PubMed ID: 18789289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of onychomycosis with oral antifungal agents.
    Iorizzo M; Piraccini BM; Rech G; Tosti A
    Expert Opin Drug Deliv; 2005 May; 2(3):435-40. PubMed ID: 16296765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current management of fungal infections.
    Meis JF; Verweij PE
    Drugs; 2001; 61 Suppl 1():13-25. PubMed ID: 11219547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.
    Haria M; Bryson HM
    Drugs; 1995 Jan; 49(1):103-20. PubMed ID: 7705210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungal infections of the perionychium.
    Yates YJ; Concannon MJ
    Hand Clin; 2002 Nov; 18(4):631-42, vi; discussion 643-6. PubMed ID: 12516978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails.
    Roberts DT
    Dermatology; 1997; 194 Suppl 1():37-9. PubMed ID: 9154400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Onychomycosis].
    Reinel D
    Hautarzt; 2004 Feb; 55(2):143-9. PubMed ID: 14968324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological periodic acid-schiff stains of nail clippings as a second-line diagnostic tool in onychomycosis.
    Mayer E; Izhak OB; Bergman R
    Am J Dermatopathol; 2012 May; 34(3):270-3. PubMed ID: 22452952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.